Citalopram
- Generic Name
- Citalopram
- Brand Names
- Celexa, Ctp
- Drug Type
- Small Molecule
- Chemical Formula
- C20H21FN2O
- CAS Number
- 59729-33-8
- Unique Ingredient Identifier
- 0DHU5B8D6V
- Background
Citalopram is an antidepressant belonging to the class of selective serotonin-reuptake inhibitors (SSRIs) widely used to treat the symptoms of depression. It is a racemic bicyclic phthalate derivate and is the only compound with a tertiary amine and 2 nitrogen-containing metabolites among all SSRIs. Citalopram enhances serotonergic transmission through the i...
- Indication
Citalopram is approved by the FDA for treating adults with major depressive disorder. It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.
- Associated Conditions
- Alcohol Abuse, Anorexia Nervosa (AN), Binge Eating Disorder (BED), Bulimia Nervosa, Depression, Diabetic Neuropathies, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Post Traumatic Stress Disorder (PTSD), Premature Ejaculation, Premenstrual Dysphoric Disorder (PMDD), Separation Anxiety Disorder, Social Anxiety Disorder (SAD)
- Associated Therapies
- -
Anxiety and Recurrent Abdominal Pain in Children
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- John V. Campo, M.D.
- Target Recruit Count
- 81
- Registration Number
- NCT00962039
- Locations
- 🇺🇸
The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
- Conditions
- Interventions
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT00955474
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Citalopram for Agitation in Alzheimer's Disease
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- JHSPH Center for Clinical Trials
- Target Recruit Count
- 186
- Registration Number
- NCT00898807
- Locations
- 🇺🇸
Monroe Community Hospital, Rochester, New York, United States
🇺🇸VA Palo Alto Health Care System, Palo Alto, California, United States
🇺🇸University of Southern California Keck School of Medicine Memory and Aging Center, Los Angeles, California, United States
Functional MRI Before and After Treatment for Depression
- Conditions
- Interventions
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 31
- Registration Number
- NCT00896441
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2009-05-05
- Target Recruit Count
- 48
- Registration Number
- NCT00893256
- Locations
- 🇮🇳
National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India
Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- University of Nebraska
- Registration Number
- NCT00876226
Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 84
- Registration Number
- NCT00834834
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Brain Effects of Escitalopram and Citalopram Using fMRI
- Conditions
- Interventions
- First Posted Date
- 2009-01-21
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- Michael Henry, MD
- Target Recruit Count
- 27
- Registration Number
- NCT00825825
- Locations
- 🇺🇸
Steward St. Elizabeth's Medical Center, Boston, Massachusetts, United States
Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations
- Conditions
- Interventions
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2009-02-11
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 18
- Registration Number
- NCT00676039
- Locations
- 🇨🇦
University of Ottawa, Institute of Mental Health Research, Ottawa, Ontario, Canada
Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2011-05-02
- Lead Sponsor
- PharmaNeuroBoost N.V.
- Target Recruit Count
- 165
- Registration Number
- NCT00672659
- Locations
- 🇬🇧
CPSResearch, Glasgow, Scotland, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.